Literature DB >> 10211489

Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance.

C Ratto1, L Sofo, M Ippoliti, M Merico, M Bossola, F M Vecchio, G B Doglietto, F Crucitti.   

Abstract

PURPOSE: Lymph-node involvement is the most important prognostic factor in colorectal cancers. Many staging systems adopted node status as a parameter of tumor classification. However, the number of identified and positive glands varies across articles, depending on specimen examination. There is a consistent risk of substaging tumors and undertreating patients. Aim of this study was to investigate the prognostic significance of different pathologic methods.
METHODS: Eight hundred one patients who underwent curative resection of colorectal cancer entered the study and were divided into two groups. In Group 1 the specimen was "en bloc" fixed, and nodes were identified by sight and palpation. In Group 2 the mesentery of the excised specimen was dissected away from the bowel, stretched, and pinned to cork board. The mesenteric segment surrounding the origin of principal vessels was divided from the segment surrounding the colic vessels. All specimen segments were fixed, node identification being performed by sight and palpation. Examined and positive nodes were recorded, and metastatic rate and incidence was calculated in the two groups. Patients were classified with use of different staging systems. Survival rates were calculated, related to tumor stage, and compared statistically. Pathologic procedures were included in a multivariate analysis.
RESULTS: A significantly higher number of detected and positive nodes and metastatic rate (37.5 vs. 30.2 percent; P < 0.05) were observed in Group 2; 45.2 percent of Group 2 and 25.3 percent of Group 1 cases had more than three positive nodes (P < 0.05). In Group 2 several patients shifted from earlier to more advanced stages compared with Group 1 cases. Five-year and ten-year survival rates were significantly higher (P = 0.04) in Group 2 (81.5 and 77.2 percent) than in Group 1 (76.7 and 61.5 percent), mostly in patients with TNM Stage N0. Survival analysis related to Astler and Coller's and Tang's classifications confirmed such features. Higher rates of local recurrences and distant metastases were found in Group 1, particularly if related to node status (P < 0.05). Multivariate analysis demonstrated the pathologic method is an independent prognostic factor.
CONCLUSIONS: This study demonstrates the prognostic impact of specimen examination. Inaccurate methods could down-stage the tumor and exclude the patient from adjuvant therapies, with detrimental effects on the outcome of the case.

Entities:  

Mesh:

Year:  1999        PMID: 10211489     DOI: 10.1007/bf02237119

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  49 in total

1.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

2.  Assessing outcomes following surgery for colorectal cancer using quality of care indicators.

Authors:  Omar Vergara-Fernandez; Carol J Swallow; J Charles Victor; Brenda I O'Connor; Robert Gryphe; Helen M MacRae; Zane Cohen; Robin S McLeod
Journal:  Can J Surg       Date:  2010-08       Impact factor: 2.089

3.  Asymptomatic familial colon cancer with FDG-PET scanning for recurrent disease.

Authors:  Hugh J Freeman
Journal:  Int J Gastrointest Cancer       Date:  2005

4.  Learning curves for laparoscopic sigmoidectomy used to manage curable sigmoid colon cancer: single-institute, three-surgeon experience.

Authors:  Dong Hyun Choi; Woon Kyung Jeong; Sang-Woo Lim; Tae Sung Chung; Jung-In Park; Seok-Byung Lim; Hyo Seong Choi; Byung-Ho Nam; Hee Jin Chang; Seung-Yong Jeong
Journal:  Surg Endosc       Date:  2008-02-13       Impact factor: 4.584

5.  Extended lymphadenectomy in colon cancer is crucial.

Authors:  Hermann Kessler; Werner Hohenberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

Review 6.  Guanylyl cyclase C as a biomarker in colorectal cancer.

Authors:  Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

7.  Tumor micrometastases in mesorectal lymph nodes and their clinical significance in patients with rectal caner.

Authors:  Yang-Chun Zheng; Yu-Ying Tang; Zong-Guang Zhou; Li Li; Tian-Cai Wang; Yi-Ling Deng; Dai-Yun Chen; Wei-Ping Liu
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Total number of lymph nodes harvested is associated with better survival in stages II and III colorectal cancer.

Authors:  Pramodh Chitral Chandrasinghe; Dileepa Senajith Ediriweera; Janaki Hewavisenthi; Sumudu Kumarage; Kemal Ismail Deen
Journal:  Indian J Gastroenterol       Date:  2013-09-19

9.  [Acetone compression. A fast, standardized method to investigate gastrointestinal lymph nodes].

Authors:  O Basten; D Bandorski; C Bismarck; K Neumann; A Fisseler-Eckhoff
Journal:  Pathologe       Date:  2010-05       Impact factor: 1.011

10.  How many lymph nodes are necessary to stage early and advanced adenocarcinoma of the sigmoid colon and upper rectum?

Authors:  Sebastian Leibl; Oleksiyy Tsybrovskyy; Helmut Denk
Journal:  Virchows Arch       Date:  2003-07-03       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.